Trim 25-35% of PG exposure toward ~75% benchmark weight; hard stop at $142.64
Underweight rating validated by stacked bearish conditions: three consecutive sequential EPS declines (-35% peak-to-trough from $1.95 to $1.26), 760 bps of operating margin compression in nine months (26.2% to 18.6%), PEG of 3.79 pricing in recovery the sequential trajectory actively disproves, and technical breakdown below 10 EMA ($146.82), 50 SMA ($145.84), and 200 SMA ($146.17) simultaneously. ~75% benchmark weight represents empirically validated sweet spot: captures directional conviction while preserving dividend carry and bounded upside optionality within the ±1.5-2.0% alpha framework. Fresh short-side initiation rejected due to 2.94% annualized carry cost and 2.2% stop distance sitting inside one session's volatility after today's 2.6% intraday range.
| Position | Action |
|---|---|
| Current price zone $145-146 | Initiate scaled sells of 25-35% of PG exposure |
| Relief bounce to $147-148 (MA cluster rejection) | Add size to trim |
| Price below $144 | Avoid initiating new trim below $144 since $142.64-143.18 support zone is statistically defended |
| Confirmed weekly close below $142.64 on expanding volume | Hard stop on remaining position (full structural invalidation) |
| Residual position maintained | Rotate freed capital into 2-5 year Treasuries at ~4.5% risk-free yield |
PG is a defensive compounder with a temporary margin headwind, working innovation engine, China Baby Care recovery, and macro tailwind from higher-for-longer rates supporting a BUY rating near the 50 SMA.
| Indicator | Value | Signal |
|---|---|---|
| Close | 145.28 | bearish |
| Open | 148.90 | neutral |
| High | 149.05 | neutral |
| Low | 145.28 | bearish |
| 10 EMA | 146.82 | bearish |
| 50 SMA | 145.84 | bearish |
| 200 SMA | 146.17 | bearish |
| RSI | 47.03 | bearish |
| MACD | 0.43 | neutral |
| MACD Signal | 0.38 | neutral |
| MACD Histogram | 0.04 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Relief bounce to $147-148 (MA cluster rejection)
Then: Add size to trim
↩ rebuts: “PG cannot grow in weak consumer environment”
· concedes: Slightly negative 1-year TSR (~flat return) — framed as price of defensive admission, not thesis failure; Rich valuation at 21.95x TTM with PEG 3.79 — disputed as category error for defensive compounder; Three quarters of EPS declines — attributed to temporary input cost inflation and SG&A pressure; Range-bound with margin pressure — conceded as current state but framed as reversing
PG is a value trap: a high-quality compounder trading at a premium multiple (PEG 3.79, forward PE 19.63x) with structurally compressing margins (760 bps in nine months), fading momentum (RSI dropped 12 points in two sessions, MACD near bearish flip), incremental-only innovation, and mounting competitive headwinds from private label and DTC brands.
· concedes: PG has genuine brand moat in certain categories; Dividend track record of 65 years without a cut demonstrates capital return discipline; FCF generation is real at $13.28B absolute scale; KMB and HSY (the bull's comparables) also have their own problems
→ vs conservative: The 'dividend king' narrative and 2.94% yield is meaningless if capital base erodes faster than income stream; calling something a 'compounder' while it actively de-compounds is incorrect
→ vs conservative: PG beta of 0.377 is a trailing measure reflecting twelve months of low-volatility grinding; it does not protect from fundamental repricing when market catches on
→ vs conservative: Quality at 6.33x book and 22x earnings is fully priced in — 'fortress balance sheet' and $62.7B goodwill are not a margin of safety at current valuation, they represent a value trap
→ vs conservative: The 'buy the dip, hold for yield' playbook worked 2022-2024 when rates were falling; it fails in 'higher for longer' regime
→ vs neutral: Waiting for stabilization means watching the stock retest lower Bollinger band at 143.18 or September swing low at 142.64 — being patient is actually being a passenger losing money
→ vs neutral: The 'defensive bid' narrative is the trade that worked for the last six months and is largely played out
→ vs neutral: Momentum (RSI down 12 points), structure (below all MAs), and breadth are all confirming same direction simultaneously — waiting for stabilization contradicts all three
| Bollinger Middle (20 SMA) | 146.37 | bearish |
| Bollinger Upper Band | 149.56 | bearish |
| Bollinger Lower Band | 143.18 | bullish |
| VWMA | 146.67 | bearish |
| ATR | 2.47 | neutral |
Support: 145.28 · 143.18 · 142.64 | Resistance: 146.82 · 149.05 · 149.56
PG technical analysis shows a bearish breakdown on 2026-09-30 with price closing at 145.28, below all key moving averages after opening at 148.90 and reaching an intraday high of 149.05. The 10 EMA (146.82), 50 SMA (145.84), and 200 SMA (146.17) all sit above current price in a compressed ~$1.00 band characteristic of a range-bound environment. RSI has dropped sharply to 47.03 from 58.87 in two sessions, while MACD histogram at 0.04 is near a bearish flip—momentum has stalled at equilibrium. VWMA divergence (price below 146.67 on heavy volume) signals institutional distribution. Near-term support at 143.18 (lower Bollinger band) and 142.64 (September swing low) offer mean-reversion buy zones, while resistance sits at 146.82 (10 EMA) and 149.56 (upper band).
Market Cap
$337.4B
PE Ratio (TTM)
21.95x
Forward PE
19.63x
PEG Ratio
3.79
Price / Book
6.33x
EPS (TTM)
$6.62
Forward EPS
$7.40
Dividend Yield
2.94%
Beta
0.377
52-Week High
$167.25
52-Week Low
$137.62
50-Day Avg Price
$145.94
200-Day Avg Price
$147.62
TTM Net Income
$15.75B
TTM Profit Margin
18.4%
TTM Operating Margin
22.1%
TTM ROE
30.3%
TTM ROA
10.7%
TTM Operating Cash Flow
$19.6B
TTM FCF
$13.28B
FCF Yield
~3.9%
Annualized Dividend
~$10.2B
Dividend Payout Ratio (FCF)
~77%
Gross Margin
~48.5%
Total Assets
$126.5B
Total Equity (Stockholders')
$54.1B
Total Liabilities
$72.2B
Total Debt
$35.0B
Net Debt
$24.2B
Goodwill & Intangibles
$62.7B
Cash & Equivalents
$9.94B
Current Ratio
0.677
Inventory
$8.17B
Long-Term Debt
$22.8B
Short-Term Debt
$11.3B
Debt/Equity
64.49
Treasury Stock
$143.0B
Retained Earnings
$135.9B
Common Stock Equity
$53.3B
Working Capital
-$12.5B
CapEx
~$1.0B per quarter
Revenue 2025-06
$20,889M
Revenue 2025-09
$22,386M
Revenue 2025-12
$22,208M
Revenue 2026-03
$21,235M
Revenue 2026-06
$21,204M
Gross Profit 2025-06
$10,258M
Gross Profit 2025-09
$11,499M
Gross Profit 2026-03
$10,513M
Gross Profit 2026-06
$10,284M
Operating Income 2025-09
$5,856M
Operating Income 2026-03
$4,577M
Operating Income 2026-06
$3,950M
Operating Margin 2025-09
26.2%
Operating Margin 2026-06
18.6%
EBITDA 2025-06
$5,456M
EBITDA 2025-09
$6,992M
EBITDA 2025-12
$6,443M
EBITDA 2026-03
$5,997M
EBITDA 2026-06
$4,981M
Net Income 2025-06
$3,538M
Net Income 2025-09
$4,677M
Net Income 2025-12
$4,247M
Net Income 2026-03
$3,860M
Net Income 2026-06
$2,970M
Diluted EPS 2025-06
$1.48
Diluted EPS 2025-09
$1.95
Diluted EPS 2025-12
$1.78
Diluted EPS 2026-03
$1.63
Diluted EPS 2026-06
$1.26
OCF 2025-09
$5,408M
OCF 2025-12
$4,972M
OCF 2026-03
$4,045M
OCF 2026-06
$5,131M
FCF 2025-09
$4,208M
FCF 2025-12
$3,805M
FCF 2026-03
$3,026M
FCF 2026-06
$4,108M
Dividends Paid per Quarter
~$2.5-2.6B
Buybacks per Quarter
$0.6-2.3B
Strengths
Concerns
P&G is a high-quality, mega-cap ($337.4B) consumer staples compounder demonstrating fortress balance sheet strength with $13.28B TTM FCF and exceptional 30.3% ROE, but facing meaningful near-term headwinds from three consecutive quarters of EPS decline (driven by operating margin compression from 26.2% to 18.6%) and EBITDA downtrend over four quarters. The premium valuation (21.95x TTM PE, 6.33x P/B) is supported by strong defensive characteristics (0.377 beta), a well-covered 2.94% dividend yield backed by 65+ years of consecutive increases, and $62.7B in brand goodwill/intangibles. Near-term upside appears limited until margin stabilization materializes; the stock trades near the midpoint of its 52-week range ($137.62-$167.25) with the long-term compounding thesis intact for income and defensive investors.
Macro: A 'higher for longer' shock wave has driven 10-year Treasury yields to highest since 2007 and 30-year yields to highest since 2002, flipping the narrative from Fed cuts to rate hikes being more likely than not. Polymarket implies 97% probability of no Fed rate cuts in 2026 and 80% combined odds for at least 1 rate hike. Mortgage rates climbed to 7.58% (approaching 3-year high), and Mark Zandi warned higher rates are already damaging the economy. Cooler-than-expected inflation mid-week gave tech a relief bounce but did not reverse the yield surge. Defensive demand tailwind for PG is the primary macro benefit, though refinancing cost headwind and strong-dollar pressure on ~40%+ EM revenue are meaningful risks.